Endovascular Treatment of Patients with Ruptured Intracranial Aneurysms: A Series of 468 Patients Treated Over a 14-Year Period.
SAH
endovascular treatment
intracranial aneurysm
neurointerventional
ruptured aneurysm
Journal
Journal of the Belgian Society of Radiology
ISSN: 2514-8281
Titre abrégé: J Belg Soc Radiol
Pays: England
ID NLM: 101698198
Informations de publication
Date de publication:
2022
2022
Historique:
received:
03
06
2021
accepted:
31
01
2022
entrez:
18
4
2022
pubmed:
19
4
2022
medline:
19
4
2022
Statut:
epublish
Résumé
Non-traumatic subarachnoid hemorrhage (SAH) is an emergency usually caused by the rupture of a saccular intracranial aneurysm. Endovascular treatment (EVT) is now considered as the first therapeutic option. The aim of our study is to evaluate, over a 14-year period in a single center, the result of EVT of ruptured intracranial aneurysms. From the retrospective analysis of our prospectively maintained database, we collected data of 457 patients successfully treated by endovascular approach for a SAH. Descriptive statistics and percentages were used to report clinical and anatomical outcomes, procedure-related complications, post procedural events, morbidity and mortality. EVT was unsuccessful in eleven patients but effective in 457 patients with two patients who experienced a rebleeding (0.4%). In 6.3% of cases, a second EVT was necessary. The final aneurysm occlusion was complete (65.7%), with a neck remnant (28.2%) or incomplete (6.1%). Procedure-related complications occurred in 5.9% of patients and were associated with five clinical worsening and one death. Overall EVT-related morbidity and mortality were thus of 1.3% and 0.4% respectively. At discharge, 71% of patients had a good recovery (mRS 0-2), 11.2% had a poor outcome (mRS 3-5), and 17.8% died. This study seems to prove that high-volume centers with experienced interventional neuroradiologists carry low rates of technical failure and complication from EVT of ruptured intracranial aneurysm.
Identifiants
pubmed: 35434517
doi: 10.5334/jbsr.2550
pmc: PMC8973758
doi:
Types de publication
Journal Article
Langues
eng
Pagination
11Informations de copyright
Copyright: © 2022 The Author(s).
Déclaration de conflit d'intérêts
The authors have no competing interests to declare.
Références
Br J Neurosurg. 2010 Dec;24(6):625-32
pubmed: 20854058
J Neuroradiol. 2007 Oct;34(4):250-9
pubmed: 17765306
Radiology. 2010 Sep;256(3):916-23
pubmed: 20720074
Clin Neurol Neurosurg. 2009 Feb;111(2):179-88
pubmed: 19013012
J Neurointerv Surg. 2009 Dec;1(2):136-41
pubmed: 21994283
Curr Neurol Neurosci Rep. 2012 Feb;12(1):24-33
pubmed: 22002766
J Neuroradiol. 2015 Apr;42(2):80-5
pubmed: 25012816
N Engl J Med. 2017 Jul 20;377(3):257-266
pubmed: 28723321
Eur J Radiol. 2013 Oct;82(10):1633-7
pubmed: 23478007
Stroke. 2012 Jun;43(6):1711-37
pubmed: 22556195
Lancet. 2007 Jan 27;369(9558):306-18
pubmed: 17258671
Handb Clin Neurol. 2016;136:1303-9
pubmed: 27430470
Lancet. 2002 Oct 26;360(9342):1267-74
pubmed: 12414200
Lancet. 2005 Sep 3-9;366(9488):809-17
pubmed: 16139655
Lancet. 2017 Feb 11;389(10069):655-666
pubmed: 27637674
Cerebrovasc Dis. 2013;35(2):93-112
pubmed: 23406828
Clin Neuroradiol. 2019 Mar;29(1):125-133
pubmed: 29080036
J Neurosurg. 2018 May;128(5):1297-1303
pubmed: 28731402
Lancet Neurol. 2015 Jun;14(6):640-54
pubmed: 25987283
AJNR Am J Neuroradiol. 2005 Mar;26(3):506-14
pubmed: 15760857
AJNR Am J Neuroradiol. 2015 Sep;36(9):1682-8
pubmed: 26138136
AJNR Am J Neuroradiol. 2010 May;31(5):907-11
pubmed: 20075090
Interv Neuroradiol. 2018 Apr;24(2):117-124
pubmed: 29231793
Stroke. 2008 Apr;39(4):1347-8
pubmed: 18309166
Lancet Neurol. 2010 May;9(5):504-19
pubmed: 20398858